Others

CIPLA LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on April 30, 2019 Published on April 30, 2019

We are pleased to inform you that Cipla receives final approval for generic version of Gilead Sciences, Incs Letairis® (Ambrisentan Tabs, 5mg & 10mg)

Pdf Link: CIPLA LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 30, 2019
This article is closed for comments.
Please Email the Editor